Please use this identifier to cite or link to this item: https://etd.cput.ac.za/handle/20.500.11838/2680
DC FieldValueLanguage
dc.contributor.advisorBáthori, Nikoletta B., Profen_US
dc.contributor.advisorDe Vries, Elise., Dren_US
dc.contributor.authorShunje, Kelly Nzwanaien_US
dc.date.accessioned2018-04-17T09:42:23Z-
dc.date.available2018-04-17T09:42:23Z-
dc.date.issued2017-
dc.identifier.urihttp://hdl.handle.net/20.500.11838/2680-
dc.descriptionThesis (MTech (Chemistry))--Cape Peninsula University of Technology, 2017en_US
dc.description.abstractCrystal engineering principles were used to cocrystallize sulfa drugs, sulfapyridine (SFP) and sulfadiazine (SFD) with aromatic acids and an amine via solution crystallization. Sulfapyridine formed cocrystals with 3-nitrobenzoic acid (SFP∙3NBA), 5-bromosalicylic acid (SFP∙5BSA), 4-dimethylaminopyridine (SFP∙4DMAP) and salts with 4-nitrobenzoic acid [SFP+][4NBA-], 3,5-dinitrosalicylic acid [SFP+][DNSA-] and 3,5-dibromosalicylic acid [SFP+][DBSA-], while sulfadiazine formed a salt with 3,5-dinitrosalicylic acid [SFD+][DNSA-]. The newly formed complexes were analyzed by differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), fourier transform infrared spectroscopy (FTIR), single crystal X-ray diffraction (SCXRD), powder X-ray diffraction (PXRD) and nuclear magnetic resonance spectroscopy (1H and 13C NMR). The hydrogen bonding and crystal packing of the new solid forms were analyzed with the aid of Mercury and CrystalExplorer. The SFP and SFD compounds exhibit tautomerism. In this work it was investigated how the introduction of coformers with varying acidity provides the possibility to form a variety of synthons, and therefore disrupt the common preferred interactions within the sulfonamides. Using selected acids as coformers, the effect on crystal packing of the coformer’s substituent position was examined by using the isomers 3NBA and 4NBA. 5BSA and DBSA were employed to analyse the effect of the number of substituents on hydrogen bond formation and crystal packing. In addition, it was investigated how small structural changes in the pharmaceutical compound influences the crystal packing by cocrystallising structurally similar SFP and SFD with the same coformer. Evaluation of the change in coformer acidity was studied by using a pyridine coformer, 4DMAP, and its crystal packing was analyzed and compared to structures formed with carboxylic acid coformers. Finally, we examined how inter-conversion of tautomers promotes crystal formation by conforming to the geometric demands of the different coformers.en_US
dc.description.sponsorshipNational Research Foundation(NRF)en_US
dc.language.isoenen_US
dc.publisherCape Peninsula University of Technologyen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/za/
dc.subjectCrystallizationen_US
dc.subjectSupramolecular chemistryen_US
dc.subjectHydrogen bondingen_US
dc.subjectSulfonamidesen_US
dc.titleMulticomponent crystals of sulfapyridine and sulfadiazineen_US
dc.typeThesisen_US
Appears in Collections:Chemistry - Masters Degrees
Files in This Item:
File Description SizeFormat 
212278266-Shunje-Kelly Nzwanai-MGCHER-Chemistry-Appsc-2018.pdfThesis10.13 MBAdobe PDFThumbnail
View/Open
Show simple item record

Page view(s)

1,281
Last Week
0
Last month
2
checked on Dec 22, 2024

Download(s)

196
checked on Dec 22, 2024

Google ScholarTM

Check


This item is licensed under a Creative Commons License Creative Commons